142217-69-4 | 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-1H-purin-6-one

Packsize	Purity	Availability	Price	Discounted Price
100mg	98%(HPLC)	in stock	$48.00	$34.00
250mg	98%	in stock	$82.00	$58.00
1g	98%	in stock	$163.00	$114.00
5g	98%	in stock	$535.00	$374.00
25g	98%	in stock	$2,004.00	$1,403.00

Description

• Catalog Number: AA69771
• Chemical Name: 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-6,9-dihydro-1H-purin-6-one
• CAS Number: 142217-69-4
• Molecular Formula: C12H15N5O3
• Molecular Weight: 277.2792
• MDL Number: MFCD24624045
• SMILES: OC[C@@H]1[C@@H](O)C[C@@H](C1=C)n1cnc2c1nc(N)[nH]c2=O

Computed Properties

• Complexity: 480
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 3
• Heavy Atom Count: 20
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 2
• XLogP3: -1.3

Literature

• Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20140615

• Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors.

  Bioorganic & medicinal chemistry 20140415

• Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

  ChemMedChem 20130701

• Long-term impact of entecavir monotherapy in chronic hepatitis B patients with a partial virologic response to entecavir therapy.

  Scandinavian journal of gastroenterology 20121101

• Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders.

  Digestive diseases and sciences 20121101

• Antiviral therapy for hepatitis B virus-related decompensated cirrhosis.

  Journal of digestive diseases 20121101

• Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients.

  World journal of gastroenterology 20121021

• Highly sensitive fast determination of entecavir in rat urine by means of hydrophilic interaction chromatography-ultra-high-performance liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. A 20121012

• Long-term impact of prophylactic antiviral treatment in Hepatitis B surface antigen positive renal allograft recipients.

  Clinical nephrology 20121001

• Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20121001

• The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country.

  The European journal of health economics : HEPAC : health economics in prevention and care 20121001

• Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels.

  Journal of viral hepatitis 20121001

• What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?

  World journal of gastroenterology 20120907

• Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.

  Clinical and experimental medicine 20120901

• High rates of viral suppression after long-term entecavir treatment of Asian patients with hepatitis B e antigen-positive chronic hepatitis B.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120901

• Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.

  Journal of gastroenterology and hepatology 20120901

• Entecavir treatment of chronic hepatitis D.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120901

• Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

  Gastroenterology 20120901

• Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.

  Journal of hepatology 20120901

• Prevention and management of drug resistant hepatitis B virus infections.

  Journal of gastroenterology and hepatology 20120901

• Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.

  Journal of medical virology 20120901

• Seroconversion of hepatitis B virus surface antigen in chronic hepatitis B child treated with entecavir.

  North American journal of medical sciences 20120901

• Comparison of the antiviral effects of entecavir and adefovir dipivoxil in chronic HBV infection: a randomized control trial.

  Acta gastro-enterologica Belgica 20120901

• Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.

  Acta gastro-enterologica Belgica 20120901

• Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.

  Liver international : official journal of the International Association for the Study of the Liver 20120801

• Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.

  Journal of hepatology 20120801

• Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120801

• [Hepatitis B virus resistance to entecavir].

  Medicina clinica 20120721

• Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong.

  Journal of gastroenterology and hepatology 20120701

• Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20120701

• Current practice of chronic hepatitis B treatment in Southern Italy.

  European journal of internal medicine 20120701

• [A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of HBeAg-negative chronic hepatitis B: results at week 48].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120701

• The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.

  Langenbeck's archives of surgery 20120601

• Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis.

  International journal of clinical oncology 20120601

• Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.

  Modern rheumatology 20120601

• Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: a retrospective analysis of 49 cases.

  Clinical rheumatology 20120601

• Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20120601

• Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years.

  Alimentary pharmacology & therapeutics 20120601

• Telbivudine myopathy in a patient with chronic hepatitis B.

  International journal of clinical pharmacy 20120601

• First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice.

  Journal of viral hepatitis 20120601

• Membranous nephropathy induced by pegylated interferon alpha-2a therapy for chronic viral hepatitis B.

  Clinical nephrology 20120601

• [Impending liver failure after chemoimmunotherapy-induced reactivation of hepatitis B - successful treatment with entecavir].

  Deutsche medizinische Wochenschrift (1946) 20120601

• Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.

  The Korean journal of internal medicine 20120601

• Evaluation of a 'home-made' method to determine viral genotype and characterize mutations conferring drug resistance in chronic hepatitis B patients.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20120601

• Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20120601

• Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection.

  Clinical and molecular hepatology 20120601

• Entecavir treatment of children 2-16 years of age with chronic hepatitis B infection.

  Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20120601

• [Pharmacological treatment of acute hepatitis B].

  Medicina clinica 20120519

• Efficacy of entecavir and adefovir combination therapy for patients with lamivudine- and entecavir-resistant chronic hepatitis B.

  Digestive diseases and sciences 20120501

• Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?

  Gut 20120501

• Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901.

  Expert opinion on drug safety 20120501

• Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20120501

• Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients.

  European journal of gastroenterology & hepatology 20120501

• Safety of long-term nucleos(t)ide treatment in chronic hepatitis B.

  Expert opinion on drug safety 20120501

• New advances in chronic hepatitis B.

  Current opinion in gastroenterology 20120501

• New perspectives in the therapy of chronic hepatitis B.

  Gut 20120501

• Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes.

  Memorias do Instituto Oswaldo Cruz 20120501

• Hepatitis B virus and HIV infection.

  Seminars in liver disease 20120501

• Effect of etanercept and entecavil in a patient with rheumatoid arthritis who is a hepatitis B carrier: a review of the literature.

  Rheumatology international 20120401

• HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120401

• Entecavir in the treatment of chronic hepatitis B in kidney transplantation.

  Journal of hepatology 20120401

• Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.

  Liver international : official journal of the International Association for the Study of the Liver 20120401

• Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?

  Liver international : official journal of the International Association for the Study of the Liver 20120401

• Selection of chronic hepatitis B therapy with high barrier to resistance.

  The Lancet. Infectious diseases 20120401

• Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft.

  Journal of gastroenterology 20120401

• [Effects of entecavir on serum HBV DNA load and transformer growth factor-β(1) in patients with chronic hepatitis B].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120401

• [Anti-hepatitis B virus drugs].

  Nihon rinsho. Japanese journal of clinical medicine 20120401

• The clinical and laboratory characteristics of patients with chronic hepatitis B using current or past antiviral therapy in Korea: a multi-center, nation-wide, cross-sectional epidemiologic study.

  Gut and liver 20120401

• [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120401

• [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].

  Orvosi hetilap 20120311

• Simple scoring system predicting genotypic resistance during rescue therapy for Lamivudine-resistant chronic hepatitis B.

  Journal of clinical gastroenterology 20120301

• Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.

  Journal of hepatology 20120301

• Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog.

  Journal of gastroenterology and hepatology 20120301

• A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.

  The Journal of antimicrobial chemotherapy 20120301

• Treatment of chronic hepatitis B with nucleos(t)ide analogues.

  Hepatology research : the official journal of the Japan Society of Hepatology 20120301

• Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.

  Journal of medical virology 20120301

• Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.

  Alimentary pharmacology & therapeutics 20120301

• Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues.

  Journal of vascular and interventional radiology : JVIR 20120301

• Bioequivalence evaluation of 2 tablet formulations of entecavir in healthy chinese volunteers: a single-dose, randomized-sequence, open-label crossover study.

  Arzneimittel-Forschung 20120301

• Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation.

  Journal of viral hepatitis 20120301

• Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.

  Journal of viral hepatitis 20120301

• TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.

  PLoS pathogens 20120301

• [Entecavir therapy for patients with hepatitis B virus-related decompensated cirrhosis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20120301

• Revision and update on clinical practice guideline for liver cirrhosis.

  The Korean journal of hepatology 20120301

• High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B.

  The Korean journal of hepatology 20120301

• Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?

  Hepatitis monthly 20120301

• Hepatitis B immune globulin in liver transplantation prophylaxis: an update.

  Hepatitis monthly 20120301

• [Efficacy of entecavir treatment in hepatitis B virus-related decompensated cirrhosis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20120301

• Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.

  World journal of gastroenterology 20120227

• Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy.

  Transplant infectious disease : an official journal of the Transplantation Society 20120201

• Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20120201

• Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine.

  The Journal of antimicrobial chemotherapy 20120201

• Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B.

  Journal of viral hepatitis 20120201

• Adefovir dipivoxil in chronic hepatitis B: history and current uses.

  Expert opinion on pharmacotherapy 20120201

• Diagnostic incidence of the presence of positive HBsAg: epidemiologic, clinical, and virological characteristics.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20120201

• [Effects of entecavir and Shenxian Yiganling combination therapy on patients with HBeAg-positive chronic hepatitis B for 48 weeks].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120201

• Salting-out homogeneous liquid-liquid extraction approach applied in sample pre-processing for the quantitative determination of entecavir in human plasma by LC-MS.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120115

• Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases.

  Chemical research in toxicology 20120113

• Antiviral resistance mutations and genotype-associated amino acid substitutions in treatment-naïve hepatitis B virus-infected individuals from the Indian subcontinent.

  Intervirology 20120101

• Antiviral drug resistance testing in patients with chronic hepatitis B.

  Digestive diseases and sciences 20120101

• Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.

  Hepato-gastroenterology 20120101

• Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis.

  Joint, bone, spine : revue du rhumatisme 20120101

• Clinical study on prevention of HBV re-infection by entecavir after liver transplantation.

  Clinical transplantation 20120101

• Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy.

  Clinical biochemistry 20120101

• Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B.

  Journal of medical virology 20120101

• Phenotypic assay of a hepatitis B virus strain carrying an rtS246T variant using a new strategy.

  Journal of medical virology 20120101

• Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.

  Liver international : official journal of the International Association for the Study of the Liver 20120101

• Combined prophylaxis might still be better than monoprophylaxis with entecavir following liver transplantation for hepatitis B.

  Gastroenterology 20120101

• Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.

  International journal of medical sciences 20120101

• High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells.

  BMC gastroenterology 20120101

• Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers.

  BMC research notes 20120101

• Risk factors of gene-resistant mutations in different nucleosides.

  Hepato-gastroenterology 20120101

• Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues.

  Antiviral therapy 20120101

• Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report.

  Journal of medical case reports 20120101

• NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium.

  BMJ open 20120101

• Management of treatment failure in chronic hepatitis B.

  Journal of hepatology 20120101

• High-resolution melting and real-time PCR for quantification and detection of drug-resistant HBV mutants in a single amplicon.

  Antiviral therapy 20120101

• Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation.

  Antiviral therapy 20120101

• Hepatitis B viral breakthrough associated with inappropriate preservation of entecavir.

  Indian journal of pharmacology 20120101

• Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.

  Antiviral therapy 20120101

• Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation.

  PloS one 20120101

• Effectiveness of Chinese herbal medicine in treating liver fibrosis: a systematic review and meta-analysis of randomized controlled trials.

  Chinese medicine 20120101

• Clinical implications of HBsAg quantification in patients with chronic hepatitis B.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• [Prognosis analysis of hepatitis B virus recurrence after liver transplantation: a single-center study of 38 cases].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120101

• [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20120101

• Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.

  PloS one 20120101

• Is there an association between the measurement of qualitative HBsAg and virologic response in chronic HBV infection?

  Annals of hepatology 20120101

• A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients.

  Antiviral therapy 20120101

• Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.

  PloS one 20120101

• Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings.

  AIDS research and treatment 20120101

• Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patient.

  Intervirology 20120101

• Mechanisms and biomarkers of apoptosis in liver disease and fibrosis.

  International journal of hepatology 20120101

• Effects of telbivudine treatment on the circulating CD4⁺ T-cell subpopulations in chronic hepatitis B patients.

  Mediators of inflammation 20120101

• Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.

  PloS one 20120101

• Seroconversion of hepatitis B envelope antigen (HBeAg) by entecavir in a child with chronic hepatitis B.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• Viral infection in renal transplant recipients.

  TheScientificWorldJournal 20120101

• Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.

  PloS one 20120101

• Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome.

  PloS one 20120101

• Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK.

  Pathology research international 20120101

• Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case report.

  Journal of clinical and experimental hematopathology : JCEH 20120101

• Rescue therapy for lamivudine-resistant chronic hepatitis B: adefovir monotherapy, adefovir plus lamivudine or entecavir combination therapy.

  Internal medicine (Tokyo, Japan) 20120101

• Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• Comparison of entecavir and adefovir for the treatment of chronic hepatitis B.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20120101

• Profile of users of drugs for the treatment of chronic hepatitis B available through the Brazilian Public Health System.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20120101

• Laboratory evaluation of three regimens of treatment of chronic hepatitis B: tenofovir, entecavir and combination of lamivudine and adefovir.

  Journal of laboratory physicians 20120101

• High frequency of recurrent viremia after hepatitis B e antigen seroconversion and consolidation therapy.

  Journal of clinical gastroenterology 20120101

• Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective.

  ClinicoEconomics and outcomes research : CEOR 20120101

• Cost-effectiveness analysis of antiviral treatments for HBeAg-positive chronic hepatitis B in Canada.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Management of hepatitis B in developing countries.

  World journal of hepatology 20111227

• Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

  Drugs 20111224

• Observation of genotype C infected chronic hepatitis B patients in clinical practice.

  Journal of infection in developing countries 20111213

• Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.

  Journal of viral hepatitis 20111201

• Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?

  Immunopharmacology and immunotoxicology 20111201

• Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs.

  Modern rheumatology 20111201

• Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.

  Journal of hepatology 20111201

• Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20111201

• Chronic hepatitis B infection in pregnancy illustrated by a case of successful treatment with entecavir.

  Archives of gynecology and obstetrics 20111201

• Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B.

  The Journal of antimicrobial chemotherapy 20111201

• Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.

  Paediatric drugs 20111201

• Presumed entecavir-induced ocular toxicity.

  Eye (London, England) 20111201

• Synthesis of entecavir and its novel class of analogs.

  Current protocols in nucleic acid chemistry 20111201

• Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.

  Journal of Korean medical science 20111201

• Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes.

  Clinics (Sao Paulo, Brazil) 20111201

• Factors predicting the efficacy of adefovir dipivoxil on treatment-naïve chronic hepatitis B patients at 48 weeks.

  Gut and liver 20111201

• Emerging pipeline drugs for hepatitis B infection.

  Expert opinion on emerging drugs 20111201

• Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients.

  The Korean journal of hepatology 20111201

• Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.

  The Korean journal of hepatology 20111201

• Clinical features of acute viral hepatitis B in Korea: a multi-center study.

  The Korean journal of hepatology 20111201

• Effect and Predictive Elements for 52 Weeks' Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B.

  Hepatitis monthly 20111201

• Effects of the Ganning formula on liver fibrosis in patients with chronic hepatitis B.

  Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 20111201

• [Optimization and assessment of a reverse hybridization system for the detection of HBV drug-resistant mutations].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20111201

• [Discussion on the meaning of MELD score in the opportunity of the entecavir treatment of HBeAg-negative acute-on-chronic liver failure].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20111201

• Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.

  Journal of viral hepatitis 20111101

• Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings.

  Journal of medical virology 20111101

• The management of chronic hepatitis B in Asian Americans.

  Digestive diseases and sciences 20111101

• Review article: current antiviral therapy of chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20111101

• Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia.

  Journal of acquired immune deficiency syndromes (1999) 20111101

• [A case of the usage of entecavir to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111101

• [Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20111101

• Hyperlipidemic acute pancreatitis: a possible role of antiretroviral therapy with entecavir.

  Minerva anestesiologica 20111001

• Hepatitis B virus infection and pregnancy.

  Clinics and research in hepatology and gastroenterology 20111001

• Multimedia manuscript: laparoscopic resection of hepatocellular carcinoma at segment 7: the posterior approach to anatomic resection.

  Surgical endoscopy 20111001

• Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.

  Gastroenterology 20111001

• The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir.

  Alimentary pharmacology & therapeutics 20111001

• Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.

  The American journal of gastroenterology 20111001

• Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.

  Alimentary pharmacology & therapeutics 20111001

• Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir.

  Journal of viral hepatitis 20111001

• Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance.

  Journal of viral hepatitis 20111001

• Antiviral drugs for viruses other than human immunodeficiency virus.

  Mayo Clinic proceedings 20111001

• Editorial: Measurement of HBsAg concentration during antiviral therapy of hepatitis B: who, when, and why.

  The American journal of gastroenterology 20111001

• Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.

  Hong Kong medical journal = Xianggang yi xue za zhi 20111001

• Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20111001

• HBV-related liver disease in renal insufficiency: successful antiviral therapy with entecavir.

  The International journal of artificial organs 20111001

• Chronic hepatitis B: management challenges in resource-poor countries.

  Hepatitis monthly 20111001

• Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies.

  Hepatitis monthly 20111001

• [The impact of early rapid virological response on the outcomes of hepatitis B associated acute on chronic liver failure during antiviral treatment].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20111001

• The cost-effectiveness of alternative strategies against HBV in Italy.

  Health policy (Amsterdam, Netherlands) 20110901

• Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy.

  Gut 20110901

• Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: virological breakthrough is also dependent on adherence to medication.

  Scandinavian journal of gastroenterology 20110901

• Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: a case report.

  Scandinavian journal of infectious diseases 20110901

• Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.

  Journal of gastroenterology and hepatology 20110901

• Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.

  Gut and liver 20110901

• Molecular epidemiology of hepatitis B virus.

  The Korean journal of internal medicine 20110901

• Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus.

  The Korean journal of hepatology 20110901

• [Quantitative analysis of hepatitis B surface antigen as a clinical marker].

  Rinsho byori. The Japanese journal of clinical pathology 20110901

• [Clinical antiviral effects of Peg-IFNa-2a in patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110901

• Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.

  Journal of medicinal chemistry 20110825

• Viral hepatitis in solid organ transplantation other than liver.

  Journal of hepatology 20110801

• Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B.

  Digestive diseases and sciences 20110801

• Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.

  Hepatology (Baltimore, Md.) 20110801

• Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological response.

  Hepatology (Baltimore, Md.) 20110801

• Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.

  Alimentary pharmacology & therapeutics 20110801

• Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.

  Infection 20110801

• Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss.

  The Journal of infectious diseases 20110801

• Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice.

  International journal of clinical practice 20110801

• Polymyositis associated with hepatitis B: management with entacavir and prednisolone.

  International journal of rheumatic diseases 20110801

• [Efficacy of two nucleoside analogs to treat resistant HBeAg-negative chronic hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20110801

• Recent advances in the management of chronic hepatitis B.

  Hepatitis monthly 20110801

• Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin.

  Hepatitis monthly 20110801

• Organic anion and cation transporters are possibly involved in renal excretion of entecavir in rats.

  Life sciences 20110704

• Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B.

  Digestive diseases and sciences 20110701

• Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety.

  The American journal of gastroenterology 20110701

• Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.

  Hepatology (Baltimore, Md.) 20110701

• Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B.

  Journal of medical virology 20110701

• Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20110701

• An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients.

  Journal of viral hepatitis 20110701

• Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.

  Journal of viral hepatitis 20110701

• [A case of pneumatosis cystoides intestinalis induced by steroid pulse therapy for severe acute hepatitis B].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110701

• [Evolution of hepatitis B virus quasispecies during antiviral therapy in one chronic hepatitis B patient].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110701

• Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

  Journal of viral hepatitis 20110601

• Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.

  Transplant infectious disease : an official journal of the Transplantation Society 20110601

• Simultaneous acute myeloid leukaemia and de novo acute hepatitis B: a novel management strategy.

  Leukemia research 20110601

• Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.

  Gastroenterology 20110601

• De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients.

  Hepatology international 20110601

• A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B.

  Hepatology international 20110601

• [Safety and efficacy of Entecavir combined with Adefovir in patients with chronic hepatitis B who fail to respond to nucleoside analog treatment].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20110601

• Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.

  Archives of surgery (Chicago, Ill. : 1960) 20110601

• [Interferon-based versus direct antiviral therapy in patients with chronic hepatitis B].

  Orvosi hetilap 20110529

• Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/emtricitabine) experienced patients.

  AIDS (London, England) 20110515

• Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine.

  Hepatology research : the official journal of the Japan Society of Hepatology 20110501

• Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patients.

  Diagnostic microbiology and infectious disease 20110501

• Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.

  Hepatology (Baltimore, Md.) 20110501

• The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine.

  Hepatitis monthly 20110501

• [The past, present and future treatment for chronic hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20110501

• [Interferon therapy for chronic hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20110501

• [Entecavir].

  Nihon rinsho. Japanese journal of clinical medicine 20110501

• Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients.

  Transplantation 20110427

• Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.

  Modern rheumatology 20110401

• Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.

  Journal of gastroenterology 20110401

• Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents.

  Journal of medical virology 20110401

• Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.

  Journal of viral hepatitis 20110401

• LC-ESI-MS/MS method for the quantification of entecavir in human plasma and its application to bioequivalence study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110401

• Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110401

• Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: outcome at 2 Years.

  Hepatology (Baltimore, Md.) 20110401

• Fibrosis in chronic viral hepatitis.

  Best practice & research. Clinical gastroenterology 20110401

• [Progress and perspectives in treatment of chronic hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20110401

• [Improvement of health-related quality of life in chronic hepatitis B patients treated with entecavir or adefovir].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110401

• Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.

  Journal of general internal medicine 20110301

• Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.

  Journal of hepatology 20110301

• Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20110301

• Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?

  Alimentary pharmacology & therapeutics 20110301

• Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.

  Journal of general internal medicine 20110301

• Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20110301

• Chronic hepatitis B in pregnancy: unique challenges and opportunities.

  The Korean journal of hepatology 20110301

• Multiple cerebral arterial stenosis associated with hepatitis B virus infection.

  Journal of clinical neurology (Seoul, Korea) 20110301

• Viral hepatitis B and hepatocellular carcinoma.

  Acta gastro-enterologica Belgica 20110301

• [Study on the efficacy and HBeAg seroconversion related factors of telbivudine and entecavir therapy in HBeAg positive chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20110301

• Chronic hepatitis B: integrating long-term treatment data and strategies to improve outcomes in clinical practice.

  Gastroenterology & hepatology 20110301

• Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.

  British journal of cancer 20110215

• Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B.

  Journal of hepatology 20110201

• Focus.

  Journal of hepatology 20110201

• Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.

  Journal of hepatology 20110201

• The importance of HBV genotype in HBeAg-positive chronic hepatitis B patients in whom sustained response is pursued.

  Journal of hepatology 20110201

• [Treatment of patients with lamivudine-resistant chronic hepatitis B].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201

• [Efficacy of entecavir and adefovir combination therapy in patients with chronic hepatitis B refractory to lamivudine and adefovir combination therapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201

• [Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201

• [Sequential therapy with a nucleos(t)ide analogue and interferon in patients with chronic hepatitis B: efficacy and limitations].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110201

• [The replication capacity and drug sensitivity of Adefovir dipivoxil-resistant HBV mutants in vivo].

  Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20110201

• Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B.

  Journal of hepatology 20110101

• Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies.

  Cellular & molecular immunology 20110101

• Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.

  Journal of virological methods 20110101

• Treatment of chronic hepatitis B: Evolution over two decades.

  Journal of gastroenterology and hepatology 20110101

• Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• Hepatitis B virus resistance to antiviral drugs: where are we going?

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• The impact of human immunodeficiency virus on viral hepatitis.

  Liver international : official journal of the International Association for the Study of the Liver 20110101

• An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.

  Virology journal 20110101

• Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

  Hepatology (Baltimore, Md.) 20110101

• Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study.

  BMC public health 20110101

• Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B.

  Antiviral therapy 20110101

• Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy.

  Virology journal 20110101

• Management of chronic hepatitis B patients: efficacy & limitation of nucleos(t)ide analogues.

  The Indian journal of medical research 20110101

• Evaluation of adefovir & lamivudine in chronic hepatitis B: correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis.

  The Indian journal of medical research 20110101

• Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis.

  Virology journal 20110101

• Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis.

  Virology journal 20110101

• Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: a systematic review.

  Virology journal 20110101

• Development and validation of a stability-indicating capillary zone electrophoretic method for the assessment of entecavir and its correlation with liquid chromatographic methods.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20110101

• [Treatment of chronic hepatitis B].

  La Revue du praticien 20110101

• [Current treatment of hepatitis B infection: where do the new nucleos(t)ide analogues fit in?].

  Gastroenterologia y hepatologia 20110101

• Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?

  Antiviral therapy 20110101

• Comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B virus infection: two-year follow-up data.

  Journal of clinical gastroenterology 20110101

• Severe acute hepatitis B treated with entecavir.

  Mediterranean journal of hematology and infectious diseases 20110101

• Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.

  BMC infectious diseases 20110101

• Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B.

  Hepato-gastroenterology 20110101

• Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B.

  Antiviral therapy 20110101

• De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.

  Antiviral therapy 20110101

• RNA interference and its potential applications to chronic HBV treatment: results of a Phase I safety and tolerability study.

  Antiviral therapy 20110101

• Safety and efficacy of entecavir for the treatment of chronic hepatitis B.

  Infection and drug resistance 20110101

• Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations.

  BMC infectious diseases 20110101

• Maculopapular-type drug eruption caused by entecavir.

  European journal of dermatology : EJD 20110101

• Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV.

  AIDS research and therapy 20110101

• High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B.

  PloS one 20110101

• Hepatitis B surface antigen seroreversion in a T-cell lymphoma patient.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• High rate of complete viral suppression with combination therapy in patients with chronic hepatitis B and prior treatment failure.

  Journal of clinical gastroenterology 20110101

• Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment.

  Virology journal 20110101

• Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.

  Antiviral therapy 20110101

• Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.

  Virology journal 20110101

• Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.

  Acta reumatologica portuguesa 20110101

• Non-invasive markers for hepatic fibrosis.

  BMC gastroenterology 20110101

• Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B.

  Annals of hepatology 20110101

• [Long-term therapy with nucleoside analog entecavir (baraclude) in patients with chronic hepatitis B].

  Przeglad epidemiologiczny 20110101

• Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B.

  BMC cancer 20110101

• A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy.

  ClinicoEconomics and outcomes research : CEOR 20110101

• Anti-viral therapy in chronic HBV infection: a single centre experience.

  Hepato-gastroenterology 20110101

• Acalculous cholecystitis in a patient with hepatocellular carcinoma on sorafenib.

  ISRN gastroenterology 20110101

• The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.

  International journal of hepatology 20110101

• Treatment of hepatitis B in decompensated liver cirrhosis.

  International journal of hepatology 20110101

• Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.

  PloS one 20110101

• Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case report.

  Neurologia medico-chirurgica 20110101

• Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.

  PloS one 20110101

• A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study: Adefovir versus Entercavir for Chronic Hepatitis B.

  Hepatitis monthly 20110101

• Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

  PloS one 20110101

• 8-Modified-2'-deoxyadenosine analogues induce delayed polymerization arrest during HIV-1 reverse transcription.

  PloS one 20110101

• The role of liver fibrosis assessment in the management of patients with chronic hepatitis B infection: lessons learned from a single centre experience.

  Hepatitis research and treatment 20110101

• Toll-like receptors signaling contributes to immunopathogenesis of HBV infection.

  Gastroenterology research and practice 20110101

• An open label prospective observational study to evaluate the efficacy of entecavir in HBeAg positive treatment naïve chronic hepatitis B patients in a tertiary care center in eastern India.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20110101

• Approach to chronic hepatitis B virus infection.

  JNMA; journal of the Nepal Medical Association 20110101

• Simple nucleos(t)ides as HBV prophylaxis regime of post-liver transplantation: Six-year followed up.

  World journal of hepatology 20101227

• Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.

  Gastroenterology 20101201

• Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20101201

• Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20101201

• Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

• Interview with Dr. Mark Cockett: current trends in screening for antiviral therapeutics. Interviewed by Nina N. Brahme and Devin J. Noblin.

  The Yale journal of biology and medicine 20101201

• [Treatment efficacy of clevudine, entecavir and lamivudine in treatment-naive patients with HBeAg-positive chronic hepatitis B].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20101201

• Efficacy of initial treatment with clevudine in naive patients with chronic hepatitis B.

  The Korean journal of internal medicine 20101201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101201

• Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.

  Viruses 20101201

• Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.

  Hepatology international 20101201

• Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B.

  Hepatology international 20101201

• FDA notifications. Entecavir (Baraclude®) labeling changed.

  AIDS alert 20101201

• Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients.

  World journal of gastroenterology 20101121

• HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.

  Liver international : official journal of the International Association for the Study of the Liver 20101101

• Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B.

  Journal of medical virology 20101101

• Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.

  Journal of medical virology 20101101

• The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.

  Vaccine 20101028

• Acute liver failure caused by concurrent autoimmune hepatitis and hepatitis B in a 16-year old girl.

  World journal of hepatology 20101027

• The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.

  Virology 20101025

• Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.

  Cancer 20101015

• Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir.

  Journal of clinical gastroenterology 20101001

• Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection.

  Digestive diseases and sciences 20101001

• Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

  Gastroenterology 20101001

• Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant.

  Transplantation proceedings 20101001

• Post-transplant infections: An ounce of prevention.

  Indian journal of nephrology 20101001

• [Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20101001

• Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B.

  Viruses 20101001

• Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100901

• Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.

  Journal of hepatology 20100901

• Safety evaluation of telbivudine.

  Expert opinion on drug safety 20100901

• Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20100901

• Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.

  Expert opinion on pharmacotherapy 20100901

• Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy.

  Hepatology research : the official journal of the Japan Society of Hepatology 20100901

• Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study.

  The Korean journal of hepatology 20100901

• A case of gynecomastia due to entecavir.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100901

• Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy.

  Hepatology international 20100901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100901

• [Analogs combination therapy in chronic hepatitis B: when and how?].

  Gastroenterologie clinique et biologique 20100901

• [Long-term therapy for chronic hepatitis B in HIV co-infected patients].

  Gastroenterologie clinique et biologique 20100901

• [Treatment has a positive impact on the long-term evolution of chronic hepatitis B].

  Gastroenterologie clinique et biologique 20100901

• Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.

  Transplantation 20100815

• Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.

  Digestive diseases and sciences 20100801

• Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100801

• Acute hepatitis B infection associated with drug-resistant hepatitis B virus.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100801

• Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: a review of 16 patients.

  European journal of internal medicine 20100801

• Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.

  Journal of gastroenterology and hepatology 20100801

• [Viral hepatitis in immunosuppressed patients].

  Klinicka mikrobiologie a infekcni lekarstvi 20100801

• [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20100801

• [Curative effect of Yidu Recipe in treating chronic hepatitis B patients of gan-shen yin-deficiency and damp-heat syndrome type and its influence of T-cell subsets].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20100801

• Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report.

  Viruses 20100801

• [Treatment of chronic hepatitis B. High response rate in general practice].

  MMW Fortschritte der Medizin 20100722

• Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.

  The Journal of infectious diseases 20100715

• Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma.

  Journal of viral hepatitis 20100701

• Think twice if you consider entecavir treatment in cases with lamivudine refractoriness.

  Hepatology (Baltimore, Md.) 20100701

• HBs seroconversion in a patient with acute hepatitis B treated with entecavir during immunosuppression against severe bronchiolitis obliterans in the course of chronic graft versus host disease.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100701

• Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis B.

  Liver international : official journal of the International Association for the Study of the Liver 20100701

• Resistance management in chronic hepatitis B complicated by renal failure.

  Clinical nephrology 20100701

• Hepatitis B virus-related polyarteritis nodosa presenting with multiple lung nodules and cavitary lesions.

  Chest 20100701

• [Resistance mutation patterns of hepatitis B virus in patients with suboptimal response to adefovir dipivoxil therapy after lamivudine resistance].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100701

• [Chronic hepatitis B: antiviral treatment guidelines].

  La Revue du praticien 20100620

• The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice.

  Evidence-based complementary and alternative medicine : eCAM 20100601

• Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro.

  Antiviral research 20100601

• Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro.

  Antimicrobial agents and chemotherapy 20100601

• Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection.

  Journal of hepatology 20100601

• Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.

  Journal of Korean medical science 20100601

• Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.

  Expert review of anti-infective therapy 20100601

• [Detection of HBV resistant mutations related to lamivudine, adefovir and entecavir by reverse hybridization technique].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100601

• [Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100601

• [Preventive effect of entecavir on hepatitis B flare up in HBsAg(+) breast cancer patients receiving chemotherapy].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100601

• [Genotypic resistance to entecavir in chronic hepatitis B patients].

  The Korean journal of hepatology 20100601

• Therapy with nucleos(t)ide analogues: current role in dialysis patients.

  The International journal of artificial organs 20100601

• Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series.

  European review for medical and pharmacological sciences 20100601

• [Analysis of the prophylactic effect of nucleosides against reactivation of HBV in HBsAg-positive patients with non-hepatic tumors after chemotherapy].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100601

• [Lamivudine and entecavir significantly improved the prognosis of early-to-mid stage hepatitis B related acute on chronic liver failure].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20100601

• Antiviral treatment of chronic hepatitis B virus (HBV) infections.

  Viruses 20100601

• Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.

  World journal of gastroenterology 20100528

• Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon.

  Liver international : official journal of the International Association for the Study of the Liver 20100501

• Treatment outcomes of clevudine versus lamivudine at week 48 in naïve patients with HBeAg positive chronic hepatitis B.

  Journal of Korean medical science 20100501

• [Comparison of the efficacy of 48 week-Entecavir therapy with that of Adefovir therapy for chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100501

• On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.

  Journal of gastroenterology and hepatology 20100501

• Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients.

  Journal of gastroenterology and hepatology 20100501

• Application of hepatitis B virus replication mouse model.

  World journal of gastroenterology 20100428

• Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.

  Hepatology (Baltimore, Md.) 20100401

• Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion.

  Liver international : official journal of the International Association for the Study of the Liver 20100401

• Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.

  Journal of hepatology 20100401

• Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers.

  Journal of Korean medical science 20100401

• Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.

  AIDS patient care and STDs 20100401

• [Fulminant hepatic failure with hepatitis B virus reactivation after rituximab treatment in a patient with resolved hepatitis B].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100401

• A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.

  Clinical therapeutics 20100401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100401

• Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B.

  World journal of hepatology 20100327

• Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100301

• Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.

  Journal of viral hepatitis 20100301

• Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen.

  Journal of hepatology 20100301

• Hepatitis B virus reactivation after 23 months of rituximab-based chemotherapy in an HBsAg-negative, anti-HBs-positive patient with follicular lymphoma.

  Journal of the Chinese Medical Association : JCMA 20100301

• Liver transplantation in bearers of hepatitis B associated or not with delta hepatitis in the age of the new antiviral drugs: is hyperimmune globulin still necessary?

  Transplantation proceedings 20100301

• Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.

  Hepatology international 20100301

• Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

  Hepatology international 20100301

• [Predictors for virologic response in management of chronic hepatitis B].

  The Korean journal of hepatology 20100301

• [Efficacy and predictors of the virologic response to entecavir therapy in nucleoside-naive patients with chronic hepatitis B].

  The Korean journal of hepatology 20100301

• [Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20100301

• Management of hepatitis B: Pakistan Society for the Study of Liver Diseases (PSSLD) practice guidelines.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20100301

• Hepatitis B virus-related membranous nephropathy treated with entecavir.

  Nephrology (Carlton, Vic.) 20100301

• Management of chronic hepatitis B: experience from China.

  Journal of viral hepatitis 20100301

• Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients.

  Journal of viral hepatitis 20100301

• [Economic evaluation of antiviral treatment for chronic hepatitis B: a systematic review].

  Revista peruana de medicina experimental y salud publica 20100301

• Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.

  Journal of hepatology 20100201

• Entecavir in decompensated HBV cirrhosis: the future is looking brighter.

  Journal of hepatology 20100201

• Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

  Hepatology (Baltimore, Md.) 20100201

• Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.

  Journal of Korean medical science 20100201

• Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.

  Zeitschrift fur Gastroenterologie 20100201

• [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100201

• Viral resistance in hepatitis B: prevalence and management.

  Current gastroenterology reports 20100201

• [The effect of antiviral therapy for patients with HBeAg-negative cirrhosis].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20100201

• Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.

  AIDS (London, England) 20100116

• [Protocol for the antiviral therapy of hepatitis B and D].

  Orvosi hetilap 20100103

• Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.

  Journal of viral hepatitis 20100101

• Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B.

  Clinical transplantation 20100101

• Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

  Hepatology (Baltimore, Md.) 20100101

• [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B].

  Deutsche medizinische Wochenschrift (1946) 20100101

• [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20100101

• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan.

  Hepatology research : the official journal of the Japan Society of Hepatology 20100101

• Effect of newer oral antiviral agents on future therapy of chronic hepatitis B.

  Antiviral therapy 20100101

• Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir.

  PloS one 20100101

• Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.

  Clinical therapeutics 20100101

• Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA.

  Virology journal 20100101

• Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.

  Journal of translational medicine 20100101

• Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome.

  PloS one 20100101

• Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy.

  Antiviral therapy 20100101

• Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B.

  Antiviral therapy 20100101

• Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection.

  Genome medicine 20100101

• Analogs and fibrosis regression in hepatitis B.

  Gastroenterologie clinique et biologique 20100101

• Validation of a stability-indicating RP-HPLC method for the determination of entecavir in tablet dosage form.

  Journal of AOAC International 20100101

• Treatment of hepatic encephalopathy by on-line hemodiafiltration: a case series study.

  BMC emergency medicine 20100101

• Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors.

  Antiviral therapy 20100101

• Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: insight from entecavir resistance studies.

  Antiviral therapy 20100101

• Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports.

  Journal of medical case reports 20100101

• Entecavir for hepatitis B virus flare treatment in patients with Crohn's disease.

  Hepato-gastroenterology 20100101

• A review of oral antiretroviral therapy for the treatment of chronic hepatitis B.

  The Annals of pharmacotherapy 20100101

• Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection.

  Journal of biomedicine & biotechnology 20100101

• Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.

  BMC health services research 20100101

• [The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review].

  Revista da Sociedade Brasileira de Medicina Tropical 20100101

• Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review.

  Virology journal 20100101

• Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen.

  Antiviral therapy 20100101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100101

• Recent advances in managing hepatitis B.

  F1000 medicine reports 20100101

• A personalized approach to optimize hepatitis B treatment in treatment-naive patients.

  Antiviral therapy 20100101

• New approaches to optimize treatment responses in chronic hepatitis B.

  Antiviral therapy 20100101

• Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment.

  PloS one 20100101

• Food effect on the pharmacokinetics of entecavir from dispersible tablets following oral administration in healthy Chinese volunteers.

  Arzneimittel-Forschung 20100101

• Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.

  Mediators of inflammation 20100101

• Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.

  Antiviral therapy 20100101

• Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B.

  Antiviral therapy 20100101

• Rituximab administration and reactivation of HBV.

  Hepatitis research and treatment 20100101

• Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck.

  Hepatitis research and treatment 20100101

• Can engineered 'designer' T cells outsmart chronic hepatitis B?

  Hepatitis research and treatment 20100101

• Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients.

  Mediterranean journal of hematology and infectious diseases 20100101

• Molecular diagnosis of entecavir resistance.

  Hepatitis monthly 20100101

• Entecavir therapy in Turkish adult patients with chronic hepatitis B: one-year results from Izmir province, Turkey.

  Hepatitis monthly 20100101

• Amazing results with hydroxyurea therapy in chronic hepatitis B: a preliminary report.

  Hepatitis monthly 20100101

• Multidrug-resistant hepatitis B virus strain in a chronic Turkish patient.

  Hepatitis monthly 20100101

• Hepatitis B Infection during Renal Replacement Therapy.

  Hepatitis monthly 20100101

• Genotype A2/adw2 Strain of Hepatitis B Virus in Turkey.

  Hepatitis monthly 20100101

• Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier.

  Annals of oncology : official journal of the European Society for Medical Oncology 20091201

• Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles.

  Journal of viral hepatitis 20091201

• Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.

  Journal of hepatology 20091201

• New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo.

  Current opinion in infectious diseases 20091201

• Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.

  Hepatology (Baltimore, Md.) 20091201

• [A case of HIV coinfected with hepatitis B virus treated by entecavir].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20091201

• [Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients].

  The Korean journal of hepatology 20091201

• Current status of liver diseases in Korea: hepatitis B.

  The Korean journal of hepatology 20091201

• [Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20091201

• [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20091201

• [Chronic hepatitis B therapy].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201

• [Management of side effects during antiviral therapy].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20091201

• HBV and HCV therapy.

  Viruses 20091201

• Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.

  Journal of viral hepatitis 20091101

• Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy.

  The Journal of rheumatology 20091101

• Monotherapy versus combination therapy for the treatment of chronic hepatitis B.

  Expert opinion on investigational drugs 20091101

• Entecavir for the long-term treatment of chronic hepatitis B.

  Expert review of anti-infective therapy 20091101

• The role of entecavir in preventing hepatitis B recurrence after liver transplantation.

  Journal of digestive diseases 20091101

• [Comparison of the therapeutical effects of entecavir and lamvudine in treatment of HBeAg-positive chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20091101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091101

• Current trends in chronic hepatitis B management: results of a questionnaire.

  European journal of gastroenterology & hepatology 20091001

• High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.

  European journal of haematology 20091001

• Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B.

  Journal of hepatology 20091001

• Current management of hepatitis B virus infection before and after liver transplantation.

  Liver international : official journal of the International Association for the Study of the Liver 20091001

• Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.

  Hepatology (Baltimore, Md.) 20091001

• Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.

  The Journal of antimicrobial chemotherapy 20091001

• Telbivudine for the treatment of chronic hepatitis B infection.

  Health technology assessment (Winchester, England) 20091001

• Entecavir for the treatment of chronic hepatitis B infection.

  Health technology assessment (Winchester, England) 20091001

• [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20091001

• Current status of nucleoside antivirals in chronic hepatitis B.

  Drugs of today (Barcelona, Spain : 1998) 20091001

• Hepatitis B virus infected health care workers in The Netherlands, 2000-2008.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090901

• Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand.

  Hepatology international 20090901

• The saga of entecavir.

  Hepatology international 20090901

• Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.

  Hepatology international 20090901

• Chronic hepatitis B: update 2009.

  Hepatology (Baltimore, Md.) 20090901

• [Prevention and management of hepatitis B virus reinfection after liver transplantation].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20090815

• Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients.

  Journal of gastroenterology and hepatology 20090801

• Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.

  Medical microbiology and immunology 20090801

• Antiviral therapy with nucleos(t)ide analogues for severe chronic hepatitis B.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20090801

• [A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090701

• [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].

  Mikrobiyoloji bulteni 20090701

• Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: A single center study.

  Indian journal of nephrology 20090701

• Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.

  Current opinion in organ transplantation 20090601

• Short-term entecavir therapy of chronic severe hepatitis B.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20090601

• [Spontaneous and treatment-induced virological dynamic in the plasma, PBMC and liver tissue in a patient with chronic HBV and HCV coinfection].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20090601

• Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B.

  Hepatology international 20090601

• Entecavir: a review of its use in chronic hepatitis B.

  Drugs 20090529

• Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.

  World journal of gastroenterology 20090528

• Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

  Hepatology (Baltimore, Md.) 20090501

• A sensitive method for the determination of entecavir at picogram per milliliter level in human plasma by solid phase extraction and high-pH LC-MS/MS.

  Journal of pharmaceutical and biomedical analysis 20090501

• Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.

  American journal of hematology 20090501

• Update on viral hepatitis: 2008.

  Current opinion in gastroenterology 20090501

• Antiviral resistance and hepatitis B therapy.

  Hepatology (Baltimore, Md.) 20090501

• Benefits and risks of combination therapy for hepatitis B.

  Hepatology (Baltimore, Md.) 20090501

• Hepatitis B treatment: Current best practices, avoiding resistance.

  Cleveland Clinic journal of medicine 20090501

• [Five years trial of entecavir for chronic hepatitis B patients failed with lamivudine therapy in the Chongqing area].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090501

• A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B.

  World journal of gastroenterology 20090407

• Immediate allergy, drug-induced eruption, by entecavir.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20090401

• Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.

  Journal of hepatology 20090401

• Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.

  Journal of hepatology 20090401

• The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.

  Hepatology (Baltimore, Md.) 20090401

• Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20090401

• Chronic hepatitis B: who to treat and which choice of treatment?

  Expert review of anti-infective therapy 20090401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090401

• Diagnosis and treatment of chronic hepatitis B: 2009 update.

  Minerva gastroenterologica e dietologica 20090301

• Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?

  Journal of gastroenterology and hepatology 20090301

• [A study on the treatment of chronic hepatitis B with YMDD mutation].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20090301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090301

• Hepatitis B in HIV patients: what is the current treatment and what are the challenges?

  Journal of HIV therapy 20090301

• Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naïve patient.

  Antiviral research 20090201

• Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir.

  Antiviral research 20090201

• Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.

  Journal of hepatology 20090201

• Role of combination therapy in chronic hepatitis B.

  Current gastroenterology reports 20090201

• Hepatitis B virus viral load and treatment decision.

  Hepatology (Baltimore, Md.) 20090201

• [Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].

  Deutsche medizinische Wochenschrift (1946) 20090201

• Antiviral therapy for hepatitis B virus associated hepatic failure.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20090201

• Hepatitis B therapy in children.

  Expert review of gastroenterology & hepatology 20090201

• Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: phase II clinical study in Japan.

  Journal of gastroenterology and hepatology 20090201

• Telbivudine in the treatment of chronic hepatitis B.

  Advances in therapy 20090201

• [Case-controlled study of entecavir treatment for chronic severe hepatitis B].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20090201

• Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

  Annals of internal medicine 20090120

• Hepatitis B and liver transplantation: 2008 update.

  Reviews in medical virology 20090101

• Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.

  Journal of hepatology 20090101

• Natural products as promising drug candidates for the treatment of hepatitis B and C.

  Acta pharmacologica Sinica 20090101

• Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

  Hepatology (Baltimore, Md.) 20090101

• Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapy.

  Hepatology research : the official journal of the Japan Society of Hepatology 20090101

• Antiviral therapy in acute viral hepatitis B: why and when.

  Infectious agents and cancer 20090101

• Treatment of HBeAg-positive patients with nucleos/tide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20090101

• HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon.

  Liver international : official journal of the International Association for the Study of the Liver 20090101

• HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues.

  Liver international : official journal of the International Association for the Study of the Liver 20090101

• Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides.

  Drugs 20090101

• Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.

  Journal of clinical gastroenterology 20090101

• How to compare antivirals in the treatment of chronic hepatitis B?

  Annals of clinical microbiology and antimicrobials 20090101

• On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future.

  Antiviral therapy 20090101

• Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.

  Antiviral chemistry & chemotherapy 20090101

• Tenofovir and its potential in the treatment of hepatitis B virus.

  Therapeutics and clinical risk management 20090101

• Portal pressure reduction after entecavir treatment in compensated HBV cirrhosis.

  Hepato-gastroenterology 20090101

• Fatal lactic acidosis associated with the use of combination oral medications to treat reactivation of hepatitis B.

  Journal of clinical gastroenterology 20090101

• Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.

  Journal of gastroenterology 20090101

• Entecavir to treat severe acute hepatitis B.

  Scandinavian journal of infectious diseases 20090101

• Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report.

  Virology journal 20090101

• Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials.

  Gastroenterologie clinique et biologique 20090101

• Analogs and fibrosis regression in hepatitis B.

  Gastroenterologie clinique et biologique 20090101

• Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.

  Antiviral therapy 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA.

  BMC gastroenterology 20090101

• Two types of drug-resistant hepatitis B viral strains emerging alternately and their susceptibility to combination therapy with entecavir and adefovir.

  Antiviral therapy 20090101

• Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae.

  Digestion 20090101

• Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report.

  Journal of medical case reports 20090101

• Safety and efficacy of telbivudine for the treatment of chronic hepatitis B.

  Therapeutics and clinical risk management 20090101

• Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.

  Antiviral therapy 20090101

• Hepatitis B associated monoclonal gammopathy that resolved after successful liver transplant.

  Journal of transplantation 20090101

• Prevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipients.

  Mediterranean journal of hematology and infectious diseases 20090101

• Management of HBV infection during immunosuppressive treatment.

  Mediterranean journal of hematology and infectious diseases 20090101

• Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

  Mediterranean journal of hematology and infectious diseases 20090101

• New approaches in the management of chronic hepatitis B: role of tenofovir.

  Infection and drug resistance 20090101

• Pregnancy and sexually transmitted viral infections.

  Indian journal of sexually transmitted diseases and AIDS 20090101

• Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir.

  Annals of internal medicine 20081216

• Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis.

  Annals of internal medicine 20081216

• [Protocol for the antiviral therapy of chronic hepatitis B].

  Orvosi hetilap 20081207

• Current treatment indications and strategies in chronic hepatitis B virus infection.

  World journal of gastroenterology 20081207

• Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase.

  The Journal of biological chemistry 20081205

• Understanding the molecular basis of HBV drug resistance by molecular modeling.

  Antiviral research 20081201

• A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20081201

• Entecavir: a step forward in combating hepatitis B disease.

  Expert opinion on pharmacotherapy 20081201

• Clevudine: a promising therapy for the treatment of chronic hepatitis B.

  Expert opinion on investigational drugs 20081201

• Entecavir monotherapy for lamivudine-refractory chronic hepatitis B.

  Expert review of anti-infective therapy 20081201

• [Case of fulminant hepatic failure in an elderly asymptomatic HBV carrier without proximate cause].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20081201

• [Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B].

  Acta gastroenterologica Latinoamericana 20081201

• [Therapy of chronic hepatitis B].

  Acta gastroenterologica Latinoamericana 20081201

• Therapeutic strategies for chronic hepatitis B virus infection in 2008.

  The American journal of medicine 20081201

• [The clinic features and the short-term efficacy of entecavir treatment of the HBeAG negative acute-on-chronic hepatitis B liver failure].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20081201

• [Clinilal study of medical ozone therapy in chronic hepatitis B of 20 patients].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20081201

• Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.

  Hepatology international 20081201

• How should chronic hepatitis B virus infection be managed in HIV-hepatitis B virus-coinfected patients not eligible for concomitant antiretroviral therapy?

  AIDS (London, England) 20081130

• Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.

  The American journal of gastroenterology 20081101

• Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?

  Hepatology (Baltimore, Md.) 20081101

• Entecavir therapy in a hepatitis B-related decompensated cirrhotic patient.

  Southern medical journal 20081101

• [Chronic hepatitis B: current therapy].

  Bulletin de l'Academie nationale de medecine 20081101

• [New data and recommendations of antiviral therapy of chronic hepatitis B and C].

  Der Internist 20081001

• Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma.

  British journal of haematology 20081001

• Pharmacoeconomics of entecavir treatment for chronic hepatitis B.

  Expert opinion on pharmacotherapy 20081001

• LB80380: a promising new drug for the treatment of chronic hepatitis B.

  Expert opinion on investigational drugs 20081001

• Resistance issues in treating chronic hepatitis B.

  Future microbiology 20081001

• Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20081001

• Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen?

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20081001

• Therapy of chronic hepatitis B: trends and developments.

  Current opinion in pharmacology 20081001

• Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.

  Expert review of anti-infective therapy 20081001

• [Multiple-site analysis of HBV drug-resistant mutations in 340 patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20081001

• Cost-effectiveness of entecavir versus lamivudine for the suppression of viral replication in chronic hepatitis B patients in Brazil.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20081001

• Management of chronic hepatitis B.

  Evidence report/technology assessment 20081001

• [Liver diseases].

  Gastroenterologia y hepatologia 20081001

• [High throughput detection of drug-resistance gene mutations in HBV using MALDI-TOF mass spectrometry].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20081001

• Clinical pharmacology.

  Indian journal of pharmacology 20081001

• A 36-year-old man with paresthesias and a headache.

  Arthritis and rheumatism 20080915

• Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.

  AIDS (London, England) 20080912

• Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.

  Journal of gastroenterology and hepatology 20080901

• [Short-term results of telbivudine versus entecavir treatments in HBeAg-positive chronic hepatitis B patients in China].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20080901

• Changing landscape of antiviral resistance management in chronic hepatitis B.

  Journal of gastroenterology and hepatology 20080901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080901

• Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.

  Hepatology international 20080901

• The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B.

  Hepatology international 20080901

• Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients.

  Transplantation 20080827

• A case of HIV co-infected with hepatitis B virus precore/core deletion mutant treated by entecavir.

  Hepatology research : the official journal of the Japan Society of Hepatology 20080801

• Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?

  American journal of hematology 20080801

• Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.

  European journal of gastroenterology & hepatology 20080801

• New paradigms for the treatment of chronic hepatitis B.

  Journal of gastroenterology and hepatology 20080801

• The treatment of chronic hepatitis B: Focus on adefovir-like antivirals.

  Therapeutics and clinical risk management 20080801

• Rapid re-emergence of YMDD mutation of hepatitis B virus with hepatic decompensation after lamivudine retreatment.

  World journal of gastroenterology 20080721

• Review article: current antiviral therapy of chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20080701

• Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.

  Hepatology (Baltimore, Md.) 20080701

• Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection.

  Hepatology research : the official journal of the Japan Society of Hepatology 20080601

• Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.

  Journal of hepatology 20080601

• Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis.

  Alimentary pharmacology & therapeutics 20080601

• Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?

  Journal of hepatology 20080601

• Current antiviral therapies for chronic hepatitis B.

  Hepatology research : the official journal of the Japan Society of Hepatology 20080601

• [Management of chronic hepatitis B in treatment-naive patients].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080601

• [Management of antiviral-resistant chronic hepatitis B virus infection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080601

• Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure.

  Hepatology international 20080601

• Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues.

  Hepatology international 20080601

• Management of hepatic complications in HIV-infected persons.

  The Journal of infectious diseases 20080515

• The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients.

  AIDS (London, England) 20080511

• Update on viral hepatitis: 2007.

  Current opinion in gastroenterology 20080501

• Entecavir therapy induces de novo HIV reverse-transcriptase M184V mutation in an antiretroviral therapy-naive patient.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080501

• Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.

  Hepatology (Baltimore, Md.) 20080501

• [Acute hepatitis B: is antiviral therapy indicated? Two case reports].

  Deutsche medizinische Wochenschrift (1946) 20080501

• [Interferon in hepatitis B].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Entecavir].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Resistance in hepatitis B virus].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Clinical management of patients with chronic hepatitis B virus infection].

  Enfermedades infecciosas y microbiologia clinica 20080501

• [Hepatitis B in patients with HIV infection].

  Enfermedades infecciosas y microbiologia clinica 20080501

• Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop.

  Hepatology international 20080501

• A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.

  AIDS (London, England) 20080423

• Antiviral therapy with entecavir combined with post-exposure 'prime-boost' vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.

  Virology 20080410

• Hepatitis B reactivation after thalidomide.

  Internal medicine journal 20080401

• Five-year data released for entecavir.

  AIDS patient care and STDs 20080401

• [The effect of entecavir treatment on HBV-specific immunity in patient with chronic hepatitis B and its relationship to HBeAg sero-conversion].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20080401

• Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B.

  World journal of gastroenterology 20080314

• Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

  The Lancet. Infectious diseases 20080301

• Potency of tenofovir in chronic hepatitis B: mono or combination therapy?

  Journal of hepatology 20080301

• Chronic hepatitis B: preventing, detecting, and managing viral resistance.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080301

• [Pharmacological agents for the treatment of chronic hepatitis B].

  Gastroenterologia y hepatologia 20080301

• [New treatment options in chronic hepatitis B].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20080301

• Economic implications of entecavir treatment in suppressing viral replication in chronic hepatitis B (CHB) patients in China from a perspective of the Chinese Social Security program.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080301

• Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.

  Hepatology international 20080301

• Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase.

  The Journal of biological chemistry 20080227

• [Current data on the treatment of chronic hepatitis B].

  Presse medicale (Paris, France : 1983) 20080201

• Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma.

  Journal of virological methods 20080201

• Entecavir for chronic hepatitis B: a review.

  Therapeutic drug monitoring 20080201

• [Advance in technical method and treatment for viral hepatitis].

  Rinsho byori. The Japanese journal of clinical pathology 20080201

• [Anti-viral therapy of type B chronic hepatitis. 1. Selection of evidence-based therapeutic policy].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20080110

• Changes in viral loads of lamivudine-resistant mutants during entecavir therapy.

  Hepatology research : the official journal of the Japan Society of Hepatology 20080101

• Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.

  Reviews in medical virology 20080101

• Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.

  BMC microbiology 20080101

• Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.

  Journal of managed care pharmacy : JMCP 20080101

• The search for cost-effective treatment of chronic hepatitis B.

  Journal of managed care pharmacy : JMCP 20080101

• Cost-effective pharmacologic therapies to treat chronic hepatitis B: how far have we really come?

  Journal of managed care pharmacy : JMCP 20080101

• Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs.

  Comparative hepatology 20080101

• New drugs for chronic hepatitis B: a review.

  American journal of therapeutics 20080101

• [Treatment recommendations of chronic hepatitis B. Did the world escape us?].

  Przeglad epidemiologiczny 20080101

• Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.

  Antiviral therapy 20080101

• Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.

  Antiviral therapy 20080101

• Treatment of chronic hepatitis B infection: an update of Swedish recommendations.

  Scandinavian journal of infectious diseases 20080101

• An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.

  PloS one 20080101

• [Treatment of chronic hepatitis B in HIV co-infected patients].

  Gastroenterologie clinique et biologique 20080101

• [Liver transplantation for chronic hepatitis B].

  Gastroenterologie clinique et biologique 20080101

• Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

  The Netherlands journal of medicine 20080101

• [Treatment of chronic hepatitis B].

  Gastroenterologie clinique et biologique 20080101

• Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.

  BMC infectious diseases 20080101

• Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.

  Drugs & aging 20080101

• Gateways to clinical trials. July-August 2008.

  Methods and findings in experimental and clinical pharmacology 20080101

• A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis B.

  PharmacoEconomics 20080101

• Pharmacotherapy of hepatitis B infection: a brief review.

  Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20080101

• Treatment of chronic hepatitis B: will entecavir and telbivudine do the trick?

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20080101

• Lamivudine treatment for severe acute HBV hepatitis.

  International journal of medical sciences 20080101

• An earthworm protease cleaving serum fibronectin and decreasing HBeAg in HepG2.2.15 cells.

  BMC biochemistry 20080101

• [Drugs treatment of hepatitis B].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20080101

• Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.

  Best practice & research. Clinical gastroenterology 20080101

• Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

  Best practice & research. Clinical gastroenterology 20080101

• NICE guidelines and a treatment algorithm for the management of chronic hepatitis B: a review of 12 years experience in west London.

  Antiviral therapy 20080101

• [Methodical recommendations of Asian-Pacific Association for Studying the Liver (APASL) concerning treatment of the viral hepatitis B (HBV)].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101

• Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B.

  Applied health economics and health policy 20080101

• Telbivudine: a new treatment for chronic hepatitis B.

  World journal of gastroenterology 20071214

• The anti-HIV antiviral activity of entecavir: the loss of a trusted friend?

  Journal of hepatology 20071201

• Successful treatment of an entecavir-resistant hepatitis B virus variant.

  Journal of medical virology 20071201

• Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients.

  Journal of viral hepatitis 20071201

• Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.

  Alimentary pharmacology & therapeutics 20071201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071201

• Treatment of Hepatitis B e Antigen-negative Patients.

  Current treatment options in gastroenterology 20071201

• The role of entecavir in the treatment of chronic hepatitis B.

  Therapeutics and clinical risk management 20071201

• Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naïve patient treated for chronic HBV.

  AIDS (London, England) 20071112

• [Attention-getting sexually transmitted diseases: Hepatitis B].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20071110

• Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues.

  Journal of medical virology 20071101

• The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore.

  Journal of viral hepatitis 20071101

• Management of hepatitis B in liver transplant recipients.

  Journal of viral hepatitis 20071101

• Oral antivirals for chronic hepatitis B.

  Clinics in liver disease 20071101

• Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

  Clinics in liver disease 20071101

• Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

  Gastroenterology 20071101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071101

• [Diagnosis and treatment of chronic hepatitis B. Recommendations of the Czech Hepatology Society of the J. E. Purkinje Medical Society and the Society of Infectious Medicine of the J.E. Purkinje Medical Society].

  Vnitrni lekarstvi 20071101

• Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.

  AIDS (London, England) 20071018

• Absence of a pharmacokinetic interaction between entecavir and adefovir.

  Journal of clinical pharmacology 20071001

• [Indications for antiviral therapy for chronic hepatitis B].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071001

• [Natural course and recommendation of therapy for HBV infection].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071001

• [Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071001

• [Recent therapies for hepatitis B (discussion)].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20071001

• The high incidence of the emergence of entecavir-resistant mutants among patients infected with lamivudine-resistant hepatitis B virus.

  The Tohoku journal of experimental medicine 20071001

• Entecavir: new drug. Chronic hepatitis B: a last resort.

  Prescrire international 20071001

• FDA, Bristol-Myers Squibb issue warning on hepatitis B drug.

  The AIDS reader 20071001

• [New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities].

  Medizinische Klinik (Munich, Germany : 1983) 20070915

• Stability of low concentrations of guanine-based antivirals in sucrose or maltitol solutions.

  International journal of pharmaceutics 20070905

• Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070901

• [Therapeutic options in chronic HBV infection].

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20070901

• [New advances in the treatment of chronic hepatitis B: position of entecavir].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20070901

• FDA notifications. FDA revises Baraclude labeling for HIV patients.

  AIDS alert 20070901

• Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.

  Hepatology international 20070901

• Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China.

  Hepatology international 20070901

• A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B.

  World journal of gastroenterology 20070821

• Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China.

  The Journal of antimicrobial chemotherapy 20070801

• Customizing the management of chronic hepatitis B virus infection.

  Seminars in liver disease 20070801

• Chronic hepatitis B: a wider range of therapeutic options.

  Prescrire international 20070801

• Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection.

  Therapeutics and clinical risk management 20070801

• Appropriate use of interferon for treatment of chronic hepatitis B.

  Hepatology research : the official journal of the Japan Society of Hepatology 20070701

• Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine.

  Hepatology research : the official journal of the Japan Society of Hepatology 20070701

• Improving outcomes for patients with chronic hepatitis B.

  Hepatology research : the official journal of the Japan Society of Hepatology 20070701

• Clinical update: hepatitis B.

  Gastroenterology & hepatology 20070701

• The HBV drug entecavir - effects on HIV-1 replication and resistance.

  The New England journal of medicine 20070621

• Entecavir surprise.

  The New England journal of medicine 20070621

• Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20070601

• Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients.

  Expert opinion on investigational drugs 20070601

• [Week 24 suppression of HBV in entecavir-treated chronic hepatitis B patients in whom lamivudine treatment failed is associated with efficacy at week 48].

  Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 20070601

• Update on viral hepatitis: 2006.

  Current opinion in gastroenterology 20070501

• Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety.

  Journal of viral hepatitis 20070501

• Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine.

  Hepatology (Baltimore, Md.) 20070501

• Telbivudine: a new option for the treatment of chronic hepatitis B.

  Expert opinion on biological therapy 20070501

• [Entecavir: a new hope for the treatment of chronic hepatitis B].

  Gastroenterologia y hepatologia 20070501

• Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.

  Journal of gastroenterology 20070501

• Low incidence of entecavir resistance in nucleoside-naive chronic hepatitis B patients.

  AIDS patient care and STDs 20070501

• Entecavir results in undetectable HBV in patients restarting treatment.

  AIDS patient care and STDs 20070501

• Antiretroviral therapy for patients with HIV-hepatitis B virus coinfection.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070401

• [Pharmacological properties and clinical efficacy of entecavir monohydrate (Baraclude Tablet 0.5 mg), an anti-HBV drug].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070401

• Telbivudine.

  Nature reviews. Drug discovery 20070401

• Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

  Drugs of today (Barcelona, Spain : 1998) 20070401

• FDA notifications. Entecavir revision made by FDA and BMS.

  AIDS alert 20070401

• Common hepatitis B drug linked to HIV antiviral resistance.

  Future microbiology 20070401

• Entecavir in HIV/HBV coinfection: possible HIV activity and resistance risk.

  AIDS clinical care 20070401

• Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.

  Antiviral research 20070301

• Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.

  Antimicrobial agents and chemotherapy 20070301

• New and emerging treatment of chronic hepatitis B.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070301

• Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.

  Journal of hepatology 20070301

• Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20070301

• Improving outcomes for patients with chronic hepatitis B.

  Current gastroenterology reports 20070301

• Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.

  Current molecular medicine 20070301

• Diagnosis and treatment of chronic hepatitis B: an update.

  Minerva gastroenterologica e dietologica 20070301

• Treatment of chronic hepatitis B in HIV-infected patients in 2007.

  Journal of HIV therapy 20070301

• Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.

  Yonsei medical journal 20070227

• [Drugs for hepatitis B and C infection].

  Nihon rinsho. Japanese journal of clinical medicine 20070227

• [Mechanisms of drug resistance in hepatitis viruses B and C].

  Nihon rinsho. Japanese journal of clinical medicine 20070227

• The management of HIV and hepatitis B coinfection.

  Current opinion in infectious diseases 20070201

• [Therapy with entecavir in chronic hepatitis B. BEHoLD-Study (Benefits of Entecavir for Hepatitis B Liver Disease)].

  Der Internist 20070201

• Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?

  Hepatology (Baltimore, Md.) 20070201

• Antiviral therapy and resistance with hepatitis B virus infection.

  World journal of gastroenterology 20070107

• Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

  Clinical drug investigation 20070101

• [Investigation of entecavir medication of chronic hepatitis B patients in the Chongqing area who failed lamivudine treatment].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20070101

• Treatment of HIV/HBV coinfection: clinical and virologic issues.

  AIDS reviews 20070101

• In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.

  Antiviral therapy 20070101

• Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.

  Reviews in gastroenterological disorders 20070101

• [Advances in the treatment of hepatitis B].

  Revista da Sociedade Brasileira de Medicina Tropical 20070101

• Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.

  PharmacoEconomics 20070101

• A new and short convergent synthetic strategy to carbocyclic nucleosides.

  Nucleosides, nucleotides & nucleic acids 20070101

• Special considerations and treatment of patients with HBV-HIV coinfection.

  Antiviral therapy 20070101

• Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.

  Acta gastro-enterologica Belgica 20070101

• [Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101

• Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.

  Pharmacotherapy 20061201

• Entecavir resistance is rare in nucleoside naïve patients with hepatitis B.

  Hepatology (Baltimore, Md.) 20061201

• Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?

  Hepatology (Baltimore, Md.) 20061201

• Hepatitis B virus treatment in HIV-infected patients.

  Topics in HIV medicine : a publication of the International AIDS Society, USA 20061201

• [Resistance to adefovir in patients with chronic hepatitis B].

  The Korean journal of hepatology 20061201

• Viruses and human cancer.

  The Yale journal of biology and medicine 20061201

• A case for treating high hepatitis B DNA levels before starting HIV therapy.

  AIDS (London, England) 20061128

• The 'return' of hepatitis B.

  World journal of gastroenterology 20061128

• Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects.

  Journal of clinical pharmacology 20061101

• Hepatitis B in liver transplant recipients.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20061101

• [Entecavir. Treatment of chronic hepatitis b virus infections].

  Medizinische Monatsschrift fur Pharmazeuten 20061101

• [A double-blind, double-dummy, randomized, controlled study of entecavir versus lamivudine for treatment of chronic hepatitis B].

  Zhonghua nei ke za zhi 20061101

• Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061001

• [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].

  Gastroenterologie clinique et biologique 20061001

• [Diagnostic, clinical and therapeutic implications of viral hepatitides in HIV-infected patients].

  Enfermedades infecciosas y microbiologia clinica 20061001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20061001

• [Therapy of hepatitis B virus infection].

  Praxis 20060906

• [Therapy of chronic hepatitis B].

  Revue medicale suisse 20060906

• Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B.

  Journal of hepatology 20060901

• New developments in the treatment of chronic hepatitis B.

  Expert opinion on biological therapy 20060901

• Lamivudine treatment in patients with chronic hepatitis B and cirrhosis.

  Expert opinion on pharmacotherapy 20060901

• Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis.

  The American journal of gastroenterology 20060901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060901

• Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B.

  International journal of nanomedicine 20060901

• Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents.

  Antiviral research 20060801

• A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060801

• Treatment of chronic hepatitis B.

  Nature clinical practice. Gastroenterology & hepatology 20060801

• Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20060801

• Hepatitis B virus with primary resistance to adefovir.

  The New England journal of medicine 20060720

• Chronic Hepatitis B and C--current treatment and future therapeutic prospects.

  Wiener medizinische Wochenschrift (1946) 20060701

• Antiviral options for the treatment of chronic hepatitis B.

  The Journal of antimicrobial chemotherapy 20060601

• Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.

  Gastroenterology 20060601

• Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?

  The Netherlands journal of medicine 20060601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060601

• Hepatitis B: the pathway to recovery through treatment.

  Gastroenterology clinics of North America 20060601

• Entecavir: a new treatment option for chronic hepatitis B.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060501

• Update on viral hepatitis: 2005.

  Current opinion in gastroenterology 20060501

• Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.

  Seminars in liver disease 20060501

• Hepatitis B virus-related cirrhosis: natural history and treatment.

  Seminars in liver disease 20060501

• Antiviral drug resistance: clinical consequences and molecular aspects.

  Seminars in liver disease 20060501

• Current issues and future directions in treatment.

  Seminars in liver disease 20060501

• [The use of nucleotide analogues in treating patients with chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20060501

• [Problems of and strategies in nucleotide analogues therapy for chronic hepatitis B].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20060501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060501

• Management of drug-resistant chronic hepatitis B.

  Clinics in liver disease 20060501

• Personal view: the management of chronic hepatitis B infection.

  Alimentary pharmacology & therapeutics 20060401

• A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

  The New England journal of medicine 20060309

• Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

  The New England journal of medicine 20060309

• Hepatitis B--preventable and now treatable.

  The New England journal of medicine 20060309

• Medical therapy of patients affected by HBeAg-negative chronic hepatitis B.

  Minerva gastroenterologica e dietologica 20060301

• Cellular and virological mechanisms of HBV drug resistance.

  Journal of hepatology 20060201

• New drugs 06, part I.

  Nursing 20060201

• Management of chronic hepatitis B virus infection: a new era of disease control.

  Internal medicine journal 20060201

• [Treatment of chronic hepatitis B].

  Presse medicale (Paris, France : 1983) 20060201

• [Liver transplantation for complications of hepatitis B].

  Presse medicale (Paris, France : 1983) 20060201

• Entecavir for the treatment of chronic hepatitis B virus infection.

  Clinical therapeutics 20060201

• Treatment algorithm for chronic hepatitis B in HIV-infected patients.

  Journal of hepatology 20060101

• Emerging therapeutics for chronic hepatitis B.

  Annual review of medicine 20060101

• Introduction to chronic hepatitis B infection.

  The American journal of gastroenterology 20060101

• Therapeutic options for chronic hepatitis B: considerations and controversies.

  The American journal of gastroenterology 20060101

• Looking to the future: new agents for chronic hepatitis B.

  The American journal of gastroenterology 20060101

• Optimizing management strategies in special patient populations.

  The American journal of gastroenterology 20060101

• Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.

  Annals of clinical microbiology and antimicrobials 20060101

• Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.

  International journal of medical sciences 20060101

• Liver disease: hepatitis B. Treatment of chronic hepatitis B With entecavir.

  Reviews in gastroenterological disorders 20060101

• [Entecavir--close perspective for using it].

  Przeglad epidemiologiczny 20060101

• Nucleoside analogs as anti-HBV agents.

  Current topics in medicinal chemistry 20060101

• Entecavir was more effective than lamivudine in HbeAg-positive chronic hepatitis B.

  ACP journal club 20060101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060101

• Chronic hepatitis B--who should be treated?

  MedGenMed : Medscape general medicine 20060101

• Entecavir: a review of its use in chronic hepatitis B.

  Drugs 20060101

• [Treatment of viral hepatitis (I). Treatment of chronic hepatitis B].

  Enfermedades infecciosas y microbiologia clinica 20060101

• Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B.

  Drugs 20060101

• Treating chronic hepatitis B: today and tomorrow.

  Current medicinal chemistry 20060101

• One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.

  Antiviral therapy 20060101

• Pegylated interferons for the treatment of chronic hepatitis B.

  Recent patents on anti-infective drug discovery 20060101

• Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation.

  Journal of hepatology 20051201

• Complications in treating chronic hepatitis B in patients with HIV.

  Expert opinion on pharmacotherapy 20051201

• Hepatitis B virus infection: current status.

  The American journal of medicine 20051201

• The current status of antiviral therapy of chronic hepatitis B.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20051201

• A review of entecavir in the treatment of chronic hepatitis B infection.

  Current medical research and opinion 20051101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20051101

• Clevudine for the treatment of chronic hepatitis B virus infection.

  Expert opinion on investigational drugs 20051001

• A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients.

  Gastroenterology 20051001

• [New aspect in the treatment of chronic hepatis B].

  Revue medicale suisse 20050907

• Managing hepatitis B coinfection in HIV-infected patients.

  Current HIV/AIDS reports 20050801

• Treatment of chronic hepatitis B.

  Journal of viral hepatitis 20050701

• [A study of the dosage and efficacy of entecavir for treating hepatitis B virus].

  Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20050701

• Entecavir.

  Nature reviews. Drug discovery 20050701

• Chronic hepatitis B--treatment with nucleoside analogues.

  The Medical journal of Malaysia 20050701

• FDA notifications. Entecavir is approved for chronic hepatitis B infection in adults.

  AIDS alert 20050701

• Entecavir (Baraclude) for chronic hepatitis B.

  The Medical letter on drugs and therapeutics 20050606

• Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

  Hepatology (Baltimore, Md.) 20050601

• Management of patients co-infected with hepatitis B virus and HIV.

  The Lancet. Infectious diseases 20050601

• Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment.

  Journal of gastroenterology 20050601

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050501

• US approves new HBV drug.

  IAPAC monthly 20050401

• [Treatment of chronic hepatitis B].

  La Revue du praticien 20050331

• Current and future treatment of chronic hepatitis B.

  Minerva gastroenterologica e dietologica 20050301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050101

• New drugs: entecavir, ibandronate sodium, and pegaptanib sodium.

  Journal of the American Pharmacists Association : JAPhA 20050101

• Drugs in development for hepatitis B.

  Drugs 20050101

• Current treatment of chronic hepatitis B: benefits and limitations.

  Seminars in liver disease 20050101

• Clinical trial results of new therapies for HBV: implications for treatment guidelines.

  Seminars in liver disease 20050101

• Management of HBV/HIV-coinfected Patients.

  Seminars in liver disease 20050101

• Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV.

  Antiviral therapy 20050101

• Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.

  Annals of clinical microbiology and antimicrobials 20050101

• New treatment for chronic hepatitis B.

  FDA consumer 20050101

• Entecavir for the treatment of chronic hepatitis B.

  Expert review of anti-infective therapy 20041201

• Management of hepatitis B patients with antiviral resistance.

  Antiviral therapy 20041201

• [Treatment of hepatitis B].

  Orvosi hetilap 20041107

• Emerging treatments in chronic hepatitis B.

  Expert opinion on emerging drugs 20041101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041101

• Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro.

  Antimicrobial agents and chemotherapy 20041001

• Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.

  Antimicrobial agents and chemotherapy 20040901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040901

• [Advances in the treatment of acute hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [Recent advances in the treatment of fulminant hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [Treatment and selection criteria for chronic hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [Entecavir therapy against hepatitis B].

  Nihon rinsho. Japanese journal of clinical medicine 20040801

• [New approaches in the treatment of hepatitis B].

  Deutsche medizinische Wochenschrift (1946) 20040521

• Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

  Journal of viral hepatitis 20040301

• Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies.

  The AIDS reader 20040301

• Molecular virology of hepatitis B virus.

  Seminars in liver disease 20040101

• New treatment of chronic hepatitis B.

  Seminars in liver disease 20040101

• Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

  Journal of hepatology 20031201

• [Nucleoside analogues resistance in the treatment of chronic hepatitis B virus infection].

  La Revue de medecine interne 20031201

• Treatment of hepatitis B reinfection after liver transplantation.

  Minerva chirurgica 20031001

• Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.

  Antiviral research 20031001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20031001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030901

• Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.

  Antiviral research 20030801

• Entecavir: a potent new antiviral drug for hepatitis B.

  Expert opinion on investigational drugs 20030401

• Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20030301

• Current and future antiviral agents for chronic hepatitis B.

  The Journal of antimicrobial chemotherapy 20030301

• Treatment of HBeAg-negative chronic hepatitis B.

  Seminars in liver disease 20030201

• Management of patients with decompensated HBV cirrhosis.

  Seminars in liver disease 20030201

• [Antiviral therapy for chronic viral hepatitis B and C].

  Nihon rinsho. Japanese journal of clinical medicine 20030201

• In vitro activity of potential anti-poxvirus agents.

  Antiviral research 20030101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030101

• Entecavir, FTC, L-FMAU, LdT and others.

  Journal of hepatology 20030101

• Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others).

  Journal of hepatology 20030101

• Antiviral therapy for hepatitis B virus infections: new targets and technical challenges.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20021201

• Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.

  Gastroenterology 20021201

• Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B.

  Journal of gastroenterology and hepatology 20021201

• Combination and newer therapies for chronic hepatitis B.

  Journal of gastroenterology and hepatology 20021201

• Therapy of chronic hepatitis B: current challenges and opportunities.

  Journal of viral hepatitis 20021101

• Prevention of recurrent hepatitis B post-liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20021001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021001

• Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.

  Antimicrobial agents and chemotherapy 20020801

• Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.

  Journal of hepatology 20020701

• Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.

  The American journal of gastroenterology 20020701

• Chronic hepatitis B: current and future treatment options.

  Pharmacotherapy 20020601

• Viral hepatitis.

  Current opinion in gastroenterology 20020501

• Management of patients with chronic hepatitis B.

  Journal of gastroenterology and hepatology 20020401

• Treatment of chronic hepatitis B: case selection and duration of therapy.

  Journal of gastroenterology and hepatology 20020401

• [New management strategies for hepatitis B].

  Gastroenterologie clinique et biologique 20020201

• Management of viral hepatitis B.

  Journal of gastroenterology and hepatology 20020201

• Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication.

  Antimicrobial agents and chemotherapy 20020101

• Nucleoside analogues for chronic hepatitis B.

  European journal of gastroenterology & hepatology 20011201

• Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.

  The Journal of infectious diseases 20011115

• Treatment of chronic hepatitis B.

  The Lancet. Infectious diseases 20011101

• Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.

  Hepatology (Baltimore, Md.) 20010901

• Antiviral drugs: current state of the art.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010801

• Current pharmacotherapy for hepatitis B infection.

  Expert opinion on pharmacotherapy 20010801

• Detection of hepatitis B virus resistance to antivirals.

  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010601

• Entecavir (Bristol-Myers Squibb).

  Current opinion in investigational drugs (London, England : 2000) 20010501

• The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance.

  The Journal of clinical investigation 20010215

• [Hepatitis B in children: natural history and therapy].

  Bulletin et memoires de l'Academie royale de medecine de Belgique 20010101

• Perspectives for the treatment of hepatitis B virus infections.

  International journal of antimicrobial agents 19990701

• Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus.

  Antimicrobial agents and chemotherapy 19990101

• Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.

  Antimicrobial agents and chemotherapy 19970701